CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,745.80
-15.00 (-0.85%)
At close: May 6, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 106.77 billion as of May 6, 2026.
Market Cap
106.77B
Enterprise Value
106.86B
Revenue
13.44B
Ranking
n/a
PE Ratio
62.31
Stock Price
1,745.80
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 106.77B, an increase of 21.37%. That is a compound annual growth rate of 65.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 107.69B | 27.14% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 333.73B |
| AstraZeneca Pharma India | 201.16B |
| Granules India | 173.27B |
| Rubicon Research | 160.89B |
| Jubilant Pharmova | 147.37B |
| Caplin Point Laboratories | 131.95B |
| Viyash Scientific | 89.32B |
| Procter & Gamble Health | 85.49B |